About Urotronic
Urotronic is a Healthcare company based in Plymouth (United States) founded in 2015, and was acquired by Laborie Medical in September 2023. Urethral stricture treatment devices are developed by Urotronic. Urotronic has raised $47.05 million across 4 funding rounds from investors including Laborie Medical, Legend Capital and CD Capital. Its chief executive, as recorded, is David Perry. Urotronic offers products and services including Optilume BPH Catheter System, Optilume Urethral Drug Coated Balloon, alpHaONE Wireless pH Capsule, and NXT Family of Urodynamics Systems. Its focus areas include Life Sciences, Genitourinary Disorders, Medical Devices and Therapeutics. Its legal entity is UROTRONIC INC. Its competitors include Neotract, Zenflow and Rivermark; 3 of its 3 listed competitors have raised funding.
Company details
Urotronic was founded in 2015 and is based in Plymouth, United States. Operations center on the medical device sector, specifically urological applications. A urethral device known as the Optilume drug-coated balloon has been created for stricture treatment. Balloon dilation is combined with drug delivery technology, where paclitaxel uptake is employed to restrict cell proliferation and fibrotic scar tissue formation, addressing recurrence issues.
- Headquarters Plymouth, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website urotronic.com
- Social LinkedIn X YouTube
- Acquired by Laborie Medical (Sep 2023)
- Legal Name Urotronic Inc
- Total Equity Funding$47.05M (USD)
in 4 rounds
- Latest Funding Round$954.36K (USD), Series C
Oct 2020
- InvestorsLaborie Medical
& 3 more
- Acquired byLaborie Medical
(Sep 2023)
Products & Services of Urotronic
Urotronic offers a comprehensive portfolio of products and services, including Optilume BPH Catheter System, Optilume Urethral Drug Coated Balloon, alpHaONE Wireless pH Capsule, and NXT Family of Urodynamics Systems.
Device for treating benign prostatic hyperplasia.
Balloon for anterior urethral stricture therapy.
System for wireless reflux monitoring.
Tools for assessing urinary function.
Apps and channels of Urotronic
its YouTube channel Laborie Medical Technologies Corp has 4.9K subscribers and 2 videos.
Videos from Urotronic
The most watched videos on Urotronic's YouTube channel, Laborie Medical Technologies Corp (4.9K subscribers). Click a video to play it here.
More on Laborie Medical Technologies Corp.
Funding Insights of Urotronic
Urotronic has successfully raised a total of $47.05M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $954.36 thousand completed in October 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $47.05M
- Total Rounds 4
- Last Round Series C — $954,360
- First Round $6.1M
(Jul 2018)
- Investors Count 4
All 4 funding rounds of Urotronic with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2020 | $954,360 | Series C | – | – | – |
| Oct 2020 | $20M | Series C | – | Laborie Medical | – |
| Aug 2018 | $20M | Series B | – | HM Venture Partners | |
| Jul 2018 | $6.1M | Series A | – | – | – |
4 investors in total: 4 institutional.
Investors in Urotronic
Urotronic has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Laborie Medical, Legend Capital and CD Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture Capital firm focused on multiple sectors | legendcapital.com.cn | Haidian, China | ||
| cd-pe.com | ||||
Healthcare venture capital investments are managed by HM Venture Partners. | 2019 | hmventurepartners.com | San Francisco, United States | |
Medical products for female lower urinary tract dysfunctions are provided. | 1967 | laborie.com | Mississauga, Canada |
Investor details for Urotronic
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Urotronic
15 people are tracked at Urotronic (6 in leadership, 9 in team).
| Name | Role | Group |
|---|---|---|
David Perry | CEO & President | Leadership |
Ian Schorn | VP, Clinical Affairs | Leadership |
Jill Moland CCRP | Clinical Program Director | Leadership |
Brad Andersen | VP, Operations and Quality | Leadership |
David Hendrickson | VP, R&D | Leadership |
James Wright | Director, Market Access EMEA | Leadership |
Brenda J | Clinical Manager | Team |
Justin Hartlen | Country Manager | Team |
Joshua Adamek | Analytical Chemist | Team |
Stéphane Charbonneau | Sales & Business Development | Canadian Market | Team |
Joshua Thao | Senior Quality Engineer | Team |
Mackenzie Mac Ree | Manager of Analytical Chemistry | Team |
Caroline Sowers | Chemist III | Team |
Brian Froechtenigt | Senior R&D Engineer | Team |
Samuel Morrison | Principal Engineer | Team |
Complete people profiles for Urotronic
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Urotronic
4 dated milestones of Urotronic across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Urotronic is founded.
- Funding First funding round of $6.1M.
- Funding Latest funding round, Series C, of $954K.
- Exit Acquired by Laborie Medical.
Competitors of Urotronic
Urotronic has 3 listed competitors in our database, 3 of them funded. They include Neotract, Zenflow and Rivermark.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| neotract.com | 2004 | Mountain View, United States | $137.96M | 119 | Minimally invasive devices in urology | |
| zenflow.com | 2014 | Palo Alto, United States | $48M | 25 | A device is developed to treat urinary obstruction from BPH. | |
| rivermarkmedical.com | 2021 | Milwaukee, United States | $34.16M | Medical device for benign prostatic hyperplasia treatment is developed. |
Detailed competitors of Urotronic
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Urotronic
The website of Urotronic (urotronic.com) receives about 3.7K visits a month.
- Monthly visits3.7K
▲ 19.6% vs previous month
Top companies in Genitourinary Disorders
3 companies that operate in the same segment as Urotronic (Genitourinary Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for drug-resistant bacterial infections are developed. | 2013 | Cambridge, Massachusetts, United States | USD 114.7 M | USD 59.62 M | 32 | |
Sacral neuromodulation devices are developed for urinary and bowel control. | 2013 | Irvine, California, United States | USD 143.47 M | |||
Provider of surgical devices for vertical hernia repair and abdominal wall reconstruction | 2012 | Malvern, Pennsylvania, United States | USD 104.6 M | USD 80.28 M | 209 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Urotronic
Complete news archive for Urotronic
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Urotronic
Urotronic was founded in 2015 and raised its 1st funding round 3 years after it was founded.
Urotronic is headquartered in Plymouth, United States. It is registered at Plymouth, Massachusetts, United States.
David Perry is the CEO of Urotronic, as recorded in our data.
Urotronic is a funded company, having raised a total of $47.05M across 4 funding rounds to date. The company's 1st funding round was a Series A of $6.1M, raised on Jul 2018.
Urotronic was founded in 2015 and is based in Plymouth, United States. Operations center on the medical device sector, specifically urological applications. A urethral device known as the Optilume drug-coated balloon has been created for stricture treatment. Balloon dilation is combined with drug delivery technology, where paclitaxel uptake is employed to restrict cell proliferation and fibrotic scar tissue formation, addressing recurrence issues.
Urotronic offers Optilume BPH Catheter System, Optilume Urethral Drug Coated Balloon, alpHaONE Wireless pH Capsule, and NXT Family of Urodynamics Systems.
Urotronic has 4 investors. Key investors include Laborie Medical, Legend Capital, CD Capital, and HM Venture Partners.
Urotronic operates through Urotronic Inc.
Yes. Urotronic was acquired by Laborie Medical in September 2023.